Medicaid Drug Rebate Program: Inadequate Oversight Raises Concerns about Rebates Paid to States
Description:
A letter report issued by the Government Accountability Office with an abstract that begins "To help control Medicaid spending on drugs, states receive rebates from pharmaceutical manufacturers through the Medicaid drug rebate program. Rebates are based on two prices--best price and average manufacturer price (AMP)--reported by manufacturers. Both reflect manufacturers' prices to various entities, accounting for certain financial concessions like discounts. Concerns have been raised about risin…
more
Date:
February 4, 2005
Creator:
United States. Government Accountability Office.
Item Type:
Refine your search to only
Report
Partner:
UNT Libraries Government Documents Department